Company Summary
Search
Home Page
 
Vanc Pharmaceuticals Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
June 30TradingN
Board of Directors
NamePosition
Arun Nayyar  Director of the Board
Bob Rai  Director of the Board
David Hall  Director of the Board
Eugene Beukman  Director and Corporate Secretary
  Secretary of the Board
Not Applicable (None)  President
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
30/May/2000  Canada British Columbia  
Exchange Filing Office
Location
Vancouver Regional Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Developing, manufacturing and selling infection control products  (not available) 
Securities
SymbolSecurity NameMarketStatus
NPHVanc Pharmaceuticals Inc.TSX VentureTRADING
Name HistoryFromTo
Vanc Pharmaceuticals Inc.7/Aug/2014Present
Company Facts Reconciliation
SubjectDate Returned
Spring 2015 CFR Not Received
Associations
Auditing Firm:  Meyers Norris Penny LLP
Subsidiary:  Nuva Marine Pharmaceuticals Corp.
Transfer Agent:  Computershare Investor Services Inc.
Latest Information
TypeDateTitle
News Releases  7/Mar/2016  NEWS RELEASE - VANC PHARMACEUTICALS ANNOUNCES CORPORATE UPDATE AND LAUNCH OF HEMA-FER[MARKETWIRE]
    NEWS RELEASE - VANC PHARMACEUTICALS RECOGNIZED AS THE TOP CLEAN TECHNOLOGY & LIFE SCIENCES COMPANY ON THE 2016 TSX VENTURE 50(TM)[MARKETWIRE]
    NEWS RELEASE - LAUNCHES FIRST OTC PRODUCT IN BRITISH COLUMBIA[MARKET NEWS]
Bulletins  4/May/2015  Resume Trading
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data